Syngene International Limited approved the INR 0.50 additional special dividend for the Financial Year ended March 31, 2022, at the AGM held on July 20, 2022.
Syngene International Limited Bombay S.E.
Equities
SYNGENE
INE398R01022
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
717.1 INR | +1.32% | -4.18% | +2.27% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.82% | 41.35B | |
+44.25% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- SYNGENE Stock
- SYNGENE Stock
- News Syngene International Limited
- Syngene International Limited Approves the Additional Special Dividend for the Financial Year Ended March 31, 2022